Soothing the Sting of Drug Costs by Choosing ‘Disruptor’ PBMs
Geisinger, whose Medicaid members jumped by 45% last year, is one of the payers trying to rein in prescription drug expenses partly by using smaller, transparent PBMs.
Geisinger Health Plan says it will move its prescription drug purchases next year to Navitus Health Solutions, as payers look for ways to trim prescription drug prices that are eating up tens of billions of dollars a year.
Geisinger likes to use “disruptor” pharmacy benefit managers that have a transparent drug-pricing system, according to Chief Medical Officer John Bulger, rather than one of the three giants who control four-fifths of the market and whose business models have been criticized for being rather opaque.
MORE ABOUT DAVID
David Fields is the President and CEO at Navitus Health Solutions. He provides enterprise leadership and strategic direction for Navitus, collaborating with the executive management team to maintain Navitus strategic plan and to develop and direct its goals, policies and execution. David has held leadership positions on a number of boards, including the American Heart Association, American Red Cross, Labor-Management Council and the National Conference of Christians and Jews.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
Examining Trends that Drive Informed Decisions
Now Available: 8th Annual Drug Trend Report
See the latest results and access industry insights you need to navigate current trend drivers.